"10.1371_journal.pone.0027864","plos one","2011-12-08T00:00:00Z","Carolina Gutiérrez; Laura Díaz; Alejandro Vallejo; Beatriz Hernández-Novoa; María Abad; Nadia Madrid; Viktor Dahl; Rafael Rubio; Ana M Moreno; Fernando Dronda; José Luis Casado; Enrique Navas; María Jesús Pérez-Elías; Javier Zamora; Sarah Palmer; Eduardo Muñoz; María Ángeles Muñoz-Fernández; Santiago Moreno","Infectious Diseases Department, Hospital Universitario Ramón y Cajal, and IRYCIS, Madrid, Spain; Inmunobiology Laboratory, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Karolinska Institute, Stockholm, Sweden; Infectious Diseases Unit, Hospital General Universitario Doce de Octubre, Madrid, Spain; Biostatistics Department, Hospital Universitario Ramón y Cajal, and IRYCIS, Madrid, Spain; Immunology Department, Universidad de Córdoba, Córdoba, Spain","Conceived and designed the experiments: CG LD AV BH-N SP. Performed the experiments: CG LD AV BH-N MA NM VD. Analyzed the data: SM CG LD AV BH-N JZ. Contributed reagents/materials/analysis tools: CG LD AV BH-N SP. Wrote the paper: CG LD AV BH-N SM. Approved of the final version to be published: CG LD AV BH-N MA NM VD RR AM FD JC EN MP-E JZ SP EM MM-F SM. Conceived and design the study: SM MM-F EM. Inclusion and patients follow up: RR AM FD JC EN MP-E.","Pfizer Inc. provided the drug. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2011","12","Carolina Gutiérrez","CG",18,TRUE,5,7,6,5,TRUE,TRUE,TRUE,2,"13;17",TRUE
